| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | US8101598 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 01/24/2012 | US8101597 Quetiapine salts and their polymorphs |
| 01/24/2012 | US8101596 Loxapine analogs and methods of use thereof |
| 01/24/2012 | US8101595 Antiviral indoles |
| 01/24/2012 | US8101593 Formulations of deoxycholic acid and salts thereof |
| 01/24/2012 | US8101592 Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
| 01/24/2012 | US8101591 9-aminoacyl tetracycline compounds and methods of use thereof |
| 01/24/2012 | US8101590 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 01/24/2012 | US8101589 Nitric oxide-releasing molecules |
| 01/24/2012 | US8101588 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 01/24/2012 | US8101587 Kits for nutrition supplementation |
| 01/24/2012 | US8101585 Compositions and methods for the modulation of JNK proteins |
| 01/24/2012 | US8101584 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 01/24/2012 | US8101583 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof |
| 01/24/2012 | US8101582 Topical ophthalmic compositions containing tobramycin and dexamethasone |
| 01/24/2012 | US8101581 atrial fibrillation |
| 01/24/2012 | US8101579 Methods and compositions for the treatment of gastrointestinal disorders |
| 01/24/2012 | US8101576 Compounds and their effects on feeding behaviour |
| 01/24/2012 | US8101569 Energy status of an individual by enhanced production of an endogenous fuel source |
| 01/24/2012 | US8101213 Xanthohumol compositions and methods of using same |
| 01/24/2012 | US8101209 Absorption in upper part oof digestive system; oral administering |
| 01/24/2012 | US8101207 Composition containing medicine extremely slightly soluble in water and method for preparation thereof |
| 01/24/2012 | US8101201 Compositions comprising dietary fat complexer and methods for their use |
| 01/24/2012 | US8101199 Des-methyl-tocopherol therapy for restenosis prevention |
| 01/24/2012 | US8101196 Medical gel; crosslinking |
| 01/24/2012 | US8101164 Dual phase drug release system |
| 01/24/2012 | US8101163 Transdermal compositions |
| 01/24/2012 | US8101161 Method of enhancing hair growth |
| 01/24/2012 | US8101160 Formulations for use in inhaler devices |
| 01/24/2012 | US8101159 In vivo methods of identifying compounds which target suppressed cancer cells |
| 01/24/2012 | US8101158 Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity |
| 01/24/2012 | CA2684447C Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/24/2012 | CA2677313C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 01/24/2012 | CA2674066C Therapeutic agent for diabetic neuropathy |
| 01/24/2012 | CA2671482C Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators |
| 01/24/2012 | CA2670760C Naphthyridine compounds as inhibitors of akt activity |
| 01/24/2012 | CA2666630C Agent for prophylaxis or treatment of alcohol dependence or drug dependence |
| 01/24/2012 | CA2661099C Pharmaceutical compositions comprising cefquinome |
| 01/24/2012 | CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/24/2012 | CA2642211C 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 01/24/2012 | CA2597812C Parenteral combination therapy for infective conditions with drug resistant bacterium |
| 01/24/2012 | CA2592102C Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same |
| 01/24/2012 | CA2579810C Stable pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 01/24/2012 | CA2571409C Neoglycorandomization and digitoxin analogs |
| 01/24/2012 | CA2568608C Six membered amino-amide derivatives as angiogenesis inhibitors |
| 01/24/2012 | CA2552195C 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level |
| 01/24/2012 | CA2537832C Nonsedating a-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-1, 3-dihydro-imizadole-2-thione |
| 01/24/2012 | CA2528010C 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 01/24/2012 | CA2527499C Foamable pharmaceutical compositions and methods for treating a disorder |
| 01/24/2012 | CA2526578C Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 01/24/2012 | CA2524498C 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
| 01/24/2012 | CA2522594C Mitotic kinesin inhibitor |
| 01/24/2012 | CA2520436C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/24/2012 | CA2515426C Uses and formulations for transdermal or transmucosal application of active agents |
| 01/24/2012 | CA2511582C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 01/24/2012 | CA2509159C Isophthalic acid derivatives |
| 01/24/2012 | CA2509090C Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 01/24/2012 | CA2509088C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/24/2012 | CA2500398C Preparations for use as a therapeutical agent |
| 01/24/2012 | CA2499902C Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
| 01/24/2012 | CA2499549C Isolation, purification and synthesis of procyanidin b2 and uses thereof |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2496698C 5-h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| 01/24/2012 | CA2496249C 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 01/24/2012 | CA2494340C Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 01/24/2012 | CA2490681C Avian appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 01/24/2012 | CA2487168C Novel nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/24/2012 | CA2471341C Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/24/2012 | CA2459577C An enantiomerically pure opioid diarylmethylpiperazine and methods of using same |
| 01/24/2012 | CA2455483C The use of trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl derivatives in the treatment and/or prophylaxis of obesity and its concomitant and/or secondary diseases |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2440920C Use of tramadol to delay ejaculation |
| 01/24/2012 | CA2440293C Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
| 01/24/2012 | CA2439838C (2-hydroxy)ethyl-thioureas useful as modulators of alpha2b adrenergic receptors |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/24/2012 | CA2432151C Compositions of estrogen-cyclodextrin complexes |
| 01/24/2012 | CA2431196C Black tea extract for prevention of disease |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2394327C Substituted piperazine and piperidine calcium channel blockers |
| 01/24/2012 | CA2383174C Method of treating cardio pulmonary diseases with no group compounds |
| 01/24/2012 | CA2379682C Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2269204C Anti-erbb2 antibodies |
| 01/24/2012 | CA2269078C Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/24/2012 | CA2221318C High affinity oligonucleotide ligands to growth factors |
| 01/24/2012 | CA2163748C Methods and compositions for inducing sleep |
| 01/22/2012 | CA2746922A1 Compositions and methods for increasing lean muscle mass after exercise |
| 01/20/2012 | CA2735631A1 Curcumin formulations and methods for making such formulations |
| 01/19/2012 | WO2012009723A1 C-met modulator pharmaceutical compositions |
| 01/19/2012 | WO2012009722A1 C-met modulator pharmaceutical compositions |
| 01/19/2012 | WO2012009699A2 Process for preparing antiviral compounds |
| 01/19/2012 | WO2012009688A1 Organic compounds |
| 01/19/2012 | WO2012009678A1 Therapeutically active compositions and their method of use |
| 01/19/2012 | WO2012009665A1 Temporary bone filler |
| 01/19/2012 | WO2012009663A2 New compounds for treating cancer and other diseases |
| 01/19/2012 | WO2012009649A1 Mif inhibitors and their uses |
| 01/19/2012 | WO2012009646A1 Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
| 01/19/2012 | WO2012009611A2 Methods and compositions for cancer immunotherapy |